Abstract
In March 2008 we introduced GreenLight photoselective vaporisation prostatectomy (PVP) as an option for patients with benign prostatic hyperplasia requiring surgery, including large prostates and patients in urinary retention. As part of our clinical governance all patients undergoing PVP are entered into a prospective audit measuring both validated Patient Outcome Measurements (POMs) and objective data.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
